Published in Eur J Surg Oncol on January 25, 2012
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31
New ultrasound techniques for lymph node evaluation. World J Gastroenterol (2013) 1.12
Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol (2016) 0.88
Extended lymphadenectomy in esophageal cancer is debatable. World J Surg (2013) 0.83
Prognostic biological features in neck dissection specimens. Eur Arch Otorhinolaryngol (2012) 0.79
Sentinel lymph node biopsy in esophageal cancer: an essential step towards individualized care. Ann Surg Innov Res (2014) 0.78
Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer. J Thorac Cardiovasc Surg (2016) 0.77
The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence. Int J Clin Oncol (2013) 0.76
Prognostic significance of the size and number of lymph nodes on pre and post neoadjuvant chemotherapy CT in patients with pN0 esophageal squamous cell carcinoma: a 5-year follow-up study. Oncotarget (2017) 0.75
Micrometastasis of hypopharyngeal cancer. Langenbecks Arch Surg (2014) 0.75
Lymph node micrometastasis in gastrointestinal tract cancer--a clinical aspect. Int J Clin Oncol (2013) 0.75
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer (2001) 3.02
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28
Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol (2001) 2.20
Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology (1999) 1.79
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy (2006) 1.66
Options in the management of esophageal perforation: analysis over a 12-year period. Dis Esophagus (2009) 1.63
Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg (2000) 1.61
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49
Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol (2008) 1.44
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol (2001) 1.42
The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy? J Gastrointest Surg (2008) 1.41
[Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg (1987) 1.35
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33
Molecular biology of esophageal cancer. Onkologie (2004) 1.28
[Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?]. Zentralbl Chir (2003) 1.26
Prognostic factors of resected adenocarcinoma of the esophagus. Surgery (1995) 1.24
Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. AJR Am J Roentgenol (1999) 1.23
Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg (1997) 1.23
Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol (2002) 1.20
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene (2001) 1.17
Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol (1999) 1.15
Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology (2001) 1.14
Management of upper intestinal leaks using an endoscopic vacuum-assisted closure system (E-VAC). Surg Endosc (2013) 1.14
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology (2002) 1.08
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol (2008) 1.08
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg (2010) 1.04
Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer (1994) 1.01
Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol (2008) 1.01
[Current S3 guidelines on surgical treatment of gastric carcinoma]. Chirurg (2012) 0.98
[Accidentally swallowed dentures--what is the correct diagnostic and therapeutic management?]. Zentralbl Chir (2008) 0.98
Function of the intrathoracic stomach as esophageal replacement. World J Surg (1988) 0.97
Endodissection of the thoracic esophagus. Technique and clinical results in transhiatal esophagectomy. Ann Surg (1993) 0.97
In vivo confocal laser endomicroscopy of the human liver: a novel method for assessing liver microarchitecture in real time. Endoscopy (2008) 0.96
The modified AFP score: an attempt to make the results of anti-reflux surgery comparable. Br J Surg (1991) 0.96
Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. Histol Histopathol (2002) 0.95
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer (2004) 0.94
Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors. Anticancer Res (2008) 0.94
Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients. Cancer (2000) 0.94
Return of interdigestive motor complex after abdominal surgery. End of postoperative ileus? Dig Dis Sci (1991) 0.94
Portal hyperperfusion causes disturbance of microcirculation and increased rate of hepatocellular apoptosis: investigations in heterotopic rat liver transplantation with portal vein arterialization. Transplant Proc (2006) 0.93
Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B. J Viral Hepat (2011) 0.93
Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg (1995) 0.92
Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation. Tumour Biol (2000) 0.90
Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology (2003) 0.90
High-volume centers--effect of case load on outcome in cancer surgery. Onkologie (2004) 0.90
[En-bloc resection of the esophagus in esophageal cancer]. Langenbecks Arch Chir (1988) 0.89
[Carcinoma of the esophagus--actual epidemiology in Germany]. Onkologie (2001) 0.88
Alternative shift models and the quality of patient care. An empirical study in surgical intensive care units. Langenbecks Arch Surg (2001) 0.88
Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol (2009) 0.88
[Diagnosis of and therapy for gastric cancer--work-flow]. Zentralbl Chir (2009) 0.87
Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer (2008) 0.87
Coincidence of nutritional habits and esophageal cancer in Germany. Onkologie (2001) 0.87
Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol (2002) 0.87
[How safe is high intrathoracic esophagogastrostomy?]. Chirurg (2003) 0.87
Preoperative lymph-node staging in gastrointestinal cancer--correlation between size and tumor stage. Onkologie (2002) 0.87
Barrett's esophagus: what is the poison - alkaline, biliary or acidic reflux? Dis Esophagus (2002) 0.87
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. J Surg Res (2001) 0.86
Preoperative staging and risk analysis in esophageal carcinoma. Hepatogastroenterology (1990) 0.86
Microcirculatory changes associated with gastric tube formation in the pig. Eur Surg Res (2002) 0.86
[Liver metastases: incidence and histogenesis]. Z Gastroenterol (2005) 0.85
Improved technique of heterotopic auxiliary rat liver transplantation with portal vein arterialization. Langenbecks Arch Surg (2006) 0.85
[Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors]. Chirurg (1997) 0.85
MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int J Cancer (2013) 0.85
Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc (2008) 0.85
Chronic esophagitis and subsequent morphological changes of the esophageal mucosa in Barrett's esophagus: a histological study of esophagectomy specimens. Surg Today (1994) 0.85
[Transmediastinal esophagectomy]. Langenbecks Arch Chir (1986) 0.85
Bile exposure of the denervated stomach as an esophageal substitute. Ann Thorac Surg (2001) 0.84
[Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University]. Chirurg (1992) 0.84
Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors. Oncol Rep (2008) 0.84
Thoracoscopic enucleation of esophageal leiomyomas: a feasible and safe procedure. Endoscopy (2007) 0.84
The impact of laryngeal dysplasia on the development of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.84
[Submucosal infiltration and local recurrence in pT1 low-risk rectal cancer treated by transanal endoscopic microsurgery]. Chirurg (2005) 0.84
Competition between native liver and graft in auxiliary liver transplantation in a rat model. Transplant Proc (2008) 0.84
The "steakhouse syndrome". Primary and definitive diagnosis and therapy. Surg Endosc (1989) 0.84
Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus. Dis Esophagus (1997) 0.84
[Anisoperistaltic Roux-en-Y reconstruction: rare cause for recurrent cholangitis after hepatic jejunostomy]. Chirurg (1999) 0.83